Literature DB >> 6787550

A mechanism for valproate-induced hyperammonemia.

F X Coude, D Rabier, L Cathelineau, G Grimber, P Parvy, P P Kamoun.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787550     DOI: 10.1203/00006450-198106000-00020

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


× No keyword cloud information.
  6 in total

1.  Carbamoylphosphate synthetase deficiency in an adult: deterioration due to administration of valproic acid.

Authors:  M Horiuchi; Y Imamura; N Nakamura; I Maruyama; T Saheki
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 2.  Hepatotoxicity to sodium valproate: a review.

Authors:  P R Powell-Jackson; J M Tredger; R Williams
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

3.  Hyperaminoacidemia in epileptic children treated with valproic acid.

Authors:  M Castro-Gago; E Rodrigo-Saez; I Novo-Rodriguez; M F Camiña; S Rodriguez-Segade
Journal:  Childs Nerv Syst       Date:  1990-12       Impact factor: 1.475

4.  Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA.

Authors:  F X Coude; G Grimber; P Parvy; D Rabier; F Petit
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

5.  Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid.

Authors:  K Iinuma; K Hayasaka; K Narisawa; K Tada; K Hori
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

6.  Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.

Authors:  K Kubota; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.